Abstract: The invention relates to a novel antibody and an antibody fragment that specifically bind to PD-L1 and a composition comprising the antibody or the antibody fragment. In addition, the invention relates to a nucleic acid encoding the antibody or the antibody fragment thereof, a host cell comprising the nucleic acid, and a related use. Furthermore, the invention relates to a therapeutic and diagnostic use of these antibodies and antibody fragments. Particularly, the invention relates to a combined treatment of these antibodies and antibody fragments with other therapies.
Type:
Grant
Filed:
December 27, 2018
Date of Patent:
November 29, 2022
Assignee:
Innovent Biologies (Suzhou) Co., Ltd.
Inventors:
Xiaoniu Miao, Huajing Hu, Junjian Liu, Bingliang Chen, Li Li